Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Spectrum Pharmaceuticals, Inc.    SPPI

Delayed Quote. Delayed  - 07/26 05:55:53 pm
6.505 USD   +0.54%
07/13 SPECTRUM PHARMA : Settles FOLOTYN® (pralatrexate injection) ANDA Pat..
07/11 SPECTRUM PHARMA : Biotechnology Stocks Under the Scanner -- PTC Ther..
07/06 SPECTRUM PHARMA : to Present Corporate Update at the Cantor Fitzgera..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/20/2016 07/21/2016 07/22/2016 07/25/2016 07/26/2016 Date
6.48(c) 6.5(c) 6.53(c) 6.47(c) 6.505 Last
1 394 245 606 097 726 850 493 355 145 587 Volume
+3.35% +0.31% +0.46% -0.92% +0.54% Change
More quotes
Financials ($)
Sales 2016 134 M
EBIT 2016 -56,1 M
Net income 2016 -84,4 M
Debt 2016 -
Yield 2016 -
Sales 2017 114 M
EBIT 2017 -58,9 M
Net income 2017 -78,0 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales2016 3,34x
Capi. / Sales2017 3,93x
Capitalization 448 M
More Financials
Company
Spectrum Pharmaceuticals, Inc develops and manufactures pharmaceutical products.The firm acquires, develops, and commercializes a pipeline of clinical and commercial products under the FUSILEV, FOLOTYN, ZEVALIN, MARQIBO, and BELEODAQ brands.The company was founded in December 1987 and is... 
More about the company
Surperformance© ratings of Spectrum Pharmaceuticals,
Trading Rating : Investor Rating :
More Ratings
Latest news on SPECTRUM PHARMACEUTICALS,
07/13 SPECTRUM PHARMACEUTICALS : Settles FOLOTYN® (pralatrexate injection) ANDA Patent..
07/13 SPECTRUM PHARMACEUTICALS INC : Other Events (form 8-K)
07/11 SPECTRUM PHARMACEUTICALS : Biotechnology Stocks Under the Scanner -- PTC Therape..
07/06 SPECTRUM PHARMACEUTICALS : to Present Corporate Update at the Cantor Fitzgerald'..
07/06 SPECTRUM PHARMACEUTICALS : to Present Corporate Update at the Cantor Fitzgerald&..
07/01 SPECTRUM PHARMACEUTICALS INC : Submission of Matters to a Vote of Security Holde..
06/09 SPECTRUM PHARMACEUTICALS INC : Other Events (form 8-K)
06/09 SPECTRUM PHARMACEUTICALS : Highlights an Oral Presentation on Apaziquone at the ..
06/01 SPECTRUM PHARMACEUTICALS : to Present Corporate Update at the Jefferies 2016 Hea..
05/31 SPECTRUM PHARMACEUTICALS INC : Other Events (form 8-K)
More news
Sector news : Biotechnology & Medical Research - NEC
12:45a GILEAD SCIENCES : cuts 2016 sales forecast, cites hepatitis C drugs
07/25DJGILEAD SCIENCES : Sales of Hepatitis C Drugs Fall 19% -- 2nd Update
07/25DJCELGENE : Drug Misses Secondary Endpoint in One of Its Lymphoma Trials
07/25DJGILEAD SCIENCES : Sales of Hepatitis C Drugs Fall 19% -- 3rd Update
07/25DJGILEAD SCIENCES : Sales of Hepatitis C Drugs Fall 19% -- Update
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
07/13 Spectrum Pharmaceuticals settles Folotyn patent fight with Fresenius
06/09 Spectrum and Sandoz settle Folotyn patent patent suit, Sandoz OK to sell gene..
05/25 Spectrum Pharma settles Folotyn patent squabble with Teva
05/05 Spectrum Pharmaceuticals' (SPPI) CEO Rajesh Shrotriya on Q1 2016 Results - Ea..
05/05 Spectrum Pharmaceuticals beats by $0.18, beats on revenue
Advertisement
Chart SPECTRUM PHARMACEUTICALS,
Duration : Period :
Spectrum Pharmaceuticals,  Technical Analysis Chart | SPPI | US84763A1088 | 4-Traders
Full-screen chart
Technical analysis trends SPECTRUM PHARMACE...
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 9,33 $
Spread / Average Target 44%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Rajesh C. Shrotriya Chairman & Chief Executive Officer
Joseph G. Turgeon President & Chief Operating Officer
Kurt A. Gustafson Chief Financial Officer, CAO & Executive VP
Stuart Mitchell Krassner Director
Anthony E. Maida Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
SPECTRUM PHARMACEUTICA..7.30%448
INCYTE CORPORATION-20.30%16 216
CELLTRION, INC.--.--%10 681
LONZA GROUP AG11.40%9 730
QUINTILES TRANSNATIONA..7.89%8 865
ALKERMES PLC-36.86%7 576
More Results